Back to the Top 100

No. 0 Founders & operators

Caitlyn Miller, PhD

Co-Founder and CEO, TwoStep Therapeutics • United States

Stanford-trained scientist leading a new class of multi-specific peptide-drug conjugates.

Find on LinkedIn
ShareLink copied

The Signal

Miller co-founded TwoStep Therapeutics with Stanford faculty including Nobel laureate Carolyn Bertozzi, and in September 2026 announced a 62.5 million dollar Series A and FDA clearance to begin first-in-human trials of its lead oncology program.

Who Caitlyn Miller, PhD is

Stanford-trained scientist leading a new class of multi-specific peptide-drug conjugates.

Miller co-founded TwoStep Therapeutics with Stanford faculty including Nobel laureate Carolyn Bertozzi, and in September 2026 announced a 62.5 million dollar Series A and FDA clearance to begin first-in-human trials of its lead oncology program.

Loading the full dossier

At a glance

Role
Co-Founder and CEO
Organisation
TwoStep Therapeutics
Platforms
LinkedIn
Based in
United States, North America
Influence Score 73.5editorial estimate, see how it is built
Reach (25% weight)60

Audience size across LinkedIn, X, YouTube, podcasts and newsletters.

Engagement (20% weight)64

How much the audience actually reacts, comments, shares and subscribes.

Credibility (25% weight)86

Clinical, research, operating or investing track record behind the commentary.

Consistency (15% weight)68

Publishing cadence and how reliably they show up with original work.

Industry impact (15% weight)80

Whether decision makers, policy and capital actually move on what they say.

Scores are subjective editorial estimates compiled by our research desk from public profiles and published work. They are opinion, not measurement, and they are not a judgement of any person's character or ability.

Also in Founders & operators

ShareLink copied

Did we miss something?

Change, add or remove details on this profile. Our desk reviews every request.

This profile is compiled by our research desk from public sources and is published as editorial commentary. Want a correction, an update, or your profile removed? and see our corrections and removals policy.

Related reading